Skip to content
Basic Thoughts

The Zimbabwean Government Turns Down ‘Unbalanced’ American Healthcare Assistance Deal Due to Information Fears

Health funding illustration
The proposed US financial assistance was aimed at programmes for treating and preventing HIV/Aids, tuberculosis, and malaria.

The nation of Zimbabwe has rejected a major American healthcare agreement worth $367m (272 million pounds) spanning five years over the United States' demand for confidential data.

This move was revealed after a internal memorandum dated December was leaked, revealing that President Emmerson Mnangagwa deemed the deal was "unbalanced".

A government representative has since stated that the United States was seeking biological samples for scientific study and commercial purposes but was not willing to share the benefits from any future treatments.

"We will now turn to the challenging and unfortunate task of ending our health aid in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont publicly.

Her embassy said the US had donated over $1.9bn as health assistance to Zimbabwe over the last two decades.

A medical body in Zimbabwe has called for more negotiations to secure a agreement agreeable to all parties so the country's vital HIV treatment initiative can proceed.

Broader Background

Zimbabwe's decision comes after a comparable situation in Kenya, where a high court suspended a related deal with the US after legal challenges were filed about the safety of Kenyans' medical information.

Since returning to the presidency last year, US President Donald Trump has slashed overseas assistance and shut down the US Agency for International Development (USAID).

USAID had overseen assistance for the US government, but Trump stated its spending was "inefficient" and his government was pursuing direct bilateral agreements to boost transparency and responsibility.

Based on statements, Sixteen African countries have to date signed similar agreements, representing over $18.3bn in new funding.

Specifics of the Declined Deal

The money for Zimbabwe was intended to funded "combating HIV/Aids, TB, malaria, maternal and child health, and preparing for epidemics".

"We believe this partnership could have provided extraordinary advantages for Zimbabwean communities, especially the 1.2 million men, women and children presently on antiretroviral therapy via American-funded initiatives," the Ambassador commented.

However, government spokesperson Nick Mangwana maintained the arrangement was "unfair".

"Our nation was requested to provide its genetic material and health information over an extended period, without any equivalent assurance of access to any scientific breakthroughs – like new medicines or tests – that could result from that provided information," Mangwana explained.

"Effectively, our country would provide the raw materials for medical research with no certainty that the resulting innovations would be accessible to our people if a new pandemic emerge."

National Interest and Global Health

He also noted that the US's withdrawal from the global health body and its pursuit of one-on-one health agreements were undermining frameworks already established via the global organization.

Mangwana cited its Pathogen Access and Benefit Sharing scheme designed to deal with potential global health emergencies.

"This mechanism is designed to ensure that when a country provides its information, the resulting advantages – including vaccines and treatments – are distributed fairly, not commercialised exclusively by those with the funds to create them."

The government's concerns over the US deal "must not be interpreted as hostility towards the US," Mangwana stressed.

"We are open to ongoing dialogue with our US partners on how future collaboration could be structured in a way that respects the independence and interests of each country."

Medical Community Response

The Zimbabwe College of Public Health Physicians (ZCPHP) said it recognised the official position, but recommended that talks must proceed given that a large portion of the country's HIV programmes depended on foreign aid.

"In cases where technical issues exist, including those involving information security or agreement terms, these can often be addressed through detailed discussion and mutually agreed protections," the group said.

The halted deal underscores the continuing debate between accepting vital international aid and safeguarding a country's data in an increasingly interconnected world.

About the author

Toni Curtis

A freelance writer and avid reader who explores life's simple moments through storytelling and personal essays.

Basic Thoughts

Type to search articles.